Is salicylic acid a drug in the US?

Short answer: salicylic acid is a cosmetic ingredient in the US until the product claims to treat acne. With that claim it is an OTC drug, and the monograph range is 0.5–2% salicylic acid (21 CFR 333.310(d), eCFR current to 2026-11-06).

The two routes

	Cosmetic	OTC drug (acne)
Trigger	Cleansing, beautifying, altering appearance	Claim to treat or prevent acne
Concentration	No federal cosmetic maximum	0.5–2% salicylic acid
Label	Cosmetic ingredient statement, net content, responsible party	Drug Facts panel; salicylic acid as active ingredient
Claims	“Exfoliates”, “helps clear the look of blemishes”	“Treats acne”, “acne treatment”, “prevents acne”
Facility regime	MoCRA registration and listing	Drug registration and listing; drug GMP

The dividing line is intended use, and intended use is read from the label, the website, the ads and anything else sold with the product. Two brands can ship the same formula and land on different sides of the line because of one sentence.

What tips a product into drug territory

“Treats acne”, “cures acne”, “acne treatment”, “acne therapy”.
“Kills acne bacteria”, “antibacterial” in an acne context.
Before-and-after claims that promise clearing of lesions.
A combination with benzoyl peroxide at drug levels plus an acne claim.

“Exfoliates”, “helps unclog pores” and “for blemish-prone skin” are the usual cosmetic-side alternatives. They are not magic words: if the rest of the page promises a medical outcome, the claim set still reads as a drug.

US vs EU

The EU does not have a US-style OTC monograph for this. A product claiming to treat acne may be treated as a medicinal product by the member state, and the cosmetic route caps salicylic acid by product type (3.0% rinse-off hair, 2.0% other, 0.5% for body lotion and several facial and lip products, Annex III No 98).

So the same 2% serum can be a cosmetic in the US and sit at the EU ceiling for a face product, while a 2% acne product with a treatment claim needs a Drug Facts panel in the US.

Common mistakes

Putting “treats acne” in the Amazon bullet points while the carton is a cosmetic label.
Using 2.5% and a drug claim: outside the monograph range.
Assuming the cosmetic side has a federal percentage limit. It does not; safety substantiation still applies.
Mixing routes in one line: “cosmetic acne treatment” is not a category.

Sources

21 CFR 333.310, acne active ingredients — eCFR, up to date 2026-11-06
FD&C Act sec. 201(g)(1), definition of a drug — 21 U.S.C. 321
21 CFR 700.35, cosmetics containing drug ingredients — eCFR
FDA, “Is It a Cosmetic, a Drug, or Both?” — fda.gov

Last verified: 2026-11-10.

Not legal advice, and not a guarantee of compliance or of acceptance by any authority.

Want this checked against your own formula? Run the free label check and paste your claims. It flags drug-claim triggers. It returns an issue list, not a print-ready label.